Last reviewed · How we verify
NCT04777305: POWER
The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients
NA trial testing Physical activity training in Obesity in 60 participants. Status unknown.
30 October 2024
Quick facts
| Lead sponsor | Tel Aviv University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 1 August 2021 |
| Primary completion | 30 October 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Physical activity training
Conditions studied
- Obesity — all drugs for Obesity →
- Muscle Loss — all drugs for Muscle Loss →
- Adiposity — all drugs for Adiposity →
Sponsor
Tel Aviv University
Who can join
Adults 20 to 65, any sex, with Obesity or Muscle Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine how different types of exercise regimens (resistance, aerobic, or combined exercise regimens) can be used to minimize muscle loss and mobilize body fat in severely obese patients after bariatric surgery (BS), despite the rapid surgery-induced weight loss. Additionally, the study will examine how changes in the intestinal microbiota following BS act as a mediation factor that alter tissue-specific responses in muscle and adipose tissue. The study will also evaluate the effect of different types of exercise regimens on cardiometabolic markers, endocrine response, and physical function following BS. Sixty sedentary (regular exercise \<1 hour per week) candidates to bariatric surgery at Herzliya Medical Center will be recruited to participate in this six-month-long randomized control study. Participants will be randomly assigned to either one of three exercise regimens intervention groups (aerobic, resistance, or a combined exercise regimen combining aerobic and resistance exercises) or a control group that will receive standard care. Training will be supervised and matched for metabolic equivalent (METs). The intervention will take place at the Sylvan Adams Sports Institute at Tel Aviv University and an online platform. All measurements will be taken at a presurgical baseline assessment and throughout the study, and will include changes of muscle mass and adipose tissue distribution, measured by a 3-Tesla magnetic resonance imaging (MRI); body composition- will be assessed using multichannel bioelectrical impedance (Seca); Bone mass, will be measured by a Dual-energy X-ray absorptiometry (DEXA); microbiota composition and changes will be evaluated by stool samples that will be subjected to 16S ribosomal ribonucleic acid (16s rRNA) profiling and metagenomics analysis; fasting blood samples will be used to examine endocrine control and cardiometabolic markers; anthropometric measurements to assess surgery results associations with physical activity outcomes and physical function will be assessed by several validated performance assessments, including handgrip, six-minute walk, sit-to-stand, maximum voluntary contraction, and maximal oxygen consumption (VO2max).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Exercise Modalities to Preserve Muscle Mass and Bone Health After Metabolic Bariatric Surgery.
Goldenshluger A, Friedman L, Turjeman T, Yavetz R, et al · · 2026 · PMID 42057763 · DOI 10.1002/jcsm.70289 -
Liver and Kidney volume Reduction May Underlie Metabolic Adaptation After Metabolic Bariatric Surgery: A sub-study of the "POWER" Randomized clinical trial.
Friedman L, Goldenshluger A, Turjeman T, Raziel A, et al · · 2026 · PMID 41875670 · DOI 10.1016/j.clnu.2026.106623
Verify or expand the search:
- PubMed search for NCT04777305
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physical activity training
Trials testing the same drug.
- NCT05815524 — Physical Activity in Patients With Parkinson's Disease: a "Disease Modifying" Intervention? · NA · terminated
- NCT03659968 — Initiation of Adapted Physical Activity for Patients With Advanced Pediatric Malignancies · NA · completed
- NCT03754478 — Follow-Up of Fitness in Overweight Patients Treated With Physical Activity · unknown
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Tel Aviv University trials
Trials by the same sponsor.
- NCT07430436 — Improving Self-regulation in Individuals With ADHD Through Adapted Karate Training · NA · not yet recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
- NCT07364981 — Gaze Contingent Attentional Reinforcement in Major Depressive Disorder · NA · not yet recruiting
- NCT07446127 — Adjunctive Diode Laser Therapy in Non-Surgical Periodontal Therapy · NA · recruiting
- NCT06710145 — The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04777305 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tel Aviv University
- Last refreshed: 27 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04777305.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing